MedTrace Logo

Clinical Outcomes After AcrySof® ReStor IOL Surgery in Faculty Practice at UTSW Medical Center at Dallas: A Retrospective Review

NCT00344578 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2011-03-23

No results posted yet for this study

Summary

To evaluate the clinical outcomes of AcrySof® ReSTOR® IOL for the Faculty Practice at UTSW Medical Center at Dallas

Conditions

  • Outcomes Following Restor IOL Lens Implant

Interventions

DEVICE

Restor IOL

Sponsors & Collaborators

  • University of Texas Southwestern Medical Center

    lead OTHER

Principal Investigators

  • Adam Fedyk, MD · UTSW Medical Center at Dallas

  • Vinod Mootha, MD · UTSW Medical Center at Dallas

  • James McCulley, MD · UTSW Medical Center at Dallas

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2007-07-31
Completion
2007-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00344578 on ClinicalTrials.gov